Phosphodiesterase-3 inhibition augments the myocardial infarct size-limiting effects of exenatide in mice with type 2 diabetes (Q47275749)

13 January 2018

title

Phosphodiesterase-3 inhibition augments the myocardial infarct size-limiting effects of exenatide in mice with type 2 diabetes (English)

1 reference

13 January 2018

0 references

Yumei Ye

1

1 reference

13 January 2018

Jinqiao Qian

2

1 reference

13 January 2018

Alexander C Castillo

3

1 reference

13 January 2018

Shukuan Ling

4

1 reference

13 January 2018

Hongmei Ye

5

1 reference

13 January 2018

Jose R Perez-Polo

6

1 reference

13 January 2018

Mandeep Bajaj

7

1 reference

13 January 2018

Yochai Birnbaum

8

1 reference

13 January 2018

publication date

26 October 2012

1 reference

13 January 2018

American Journal of Physiology Heart and Circulatory Physiology

published in

1 reference

13 January 2018

volume

304

1 reference

13 January 2018

page(s)

H131-41

1 reference

13 January 2018

issue

1

1 reference

13 January 2018

Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Albiglutide, a long lasting glucagon-like peptide-1 analog, protects the rat heart against ischemia/reperfusion injury: evidence for improving cardiac metabolic efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Cross-talk between PKA and Akt protects endothelial cells from apoptosis in the late ischemic preconditioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Disruption of Ang-1/Tie-2 signaling contributes to the impaired myocardial vascular maturation and angiogenesis in type II diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

p85 regulatory subunit of PI3K mediates cAMP-PKA and estrogens biological effects on growth and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Pharmacological preconditioning with resveratrol: role of CREB-dependent Bcl-2 signaling via adenosine A3 receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Glucagon-like peptide-1 (GLP-1), immediately prior to reperfusion, decreases neutrophil activation and reduces myocardial infarct size in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Mechanisms of action of glucagon-like peptide 1 in the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Diazoxide-mediated preconditioning against apoptosis involves activation of cAMP-response element-binding protein (CREB) and NFkappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

cAMP-PKA signaling to the mitochondria: protein scaffolds, mRNA and phosphatases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Myocardial infarction and heart failure in the db/db diabetic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Cytoprotective effects of N,N,N-trimethylsphingosine during ischemia- reperfusion injury are lost in the setting of obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Acute activation and phosphorylation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Survival kinases in ischemic preconditioning and postconditioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

The Physiology of Glucagon-like Peptide 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Cilostazol prevents tumor necrosis factor-alpha-induced cell death by suppression of phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and activation of Akt/cyclic AMP response element-binding protein phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Rosiglitazone treatment improves cardiac efficiency in hearts from diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Mediating delta-opioid-initiated heart protection via the beta2-adrenergic receptor: role of the intrinsic cardiac adrenergic cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Ischemic preconditioning attenuates calpain-mediated degradation of structural proteins through a protein kinase A-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Both stimulation of GLP-1 receptors and inhibition of glycogenolysis additively contribute to a protective effect of oral miglitol against ischaemia-reperfusion injury in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Cilostazol as a Unique Antithrombotic Agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Pharmacological inhibition of PTEN limits myocardial infarct size and improves left ventricular function postinfarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Resolvin E1 protects the rat heart against reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Cilostazol enhances casein kinase 2 phosphorylation and suppresses tumor necrosis factor-alpha-induced increased phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and apoptotic cell death in SK-N-SH cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

The db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of Western diet feeding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Lack of antiapoptotic effects of antiplatelet drug, aspirin and clopidogrel, and antioxidant, MCI-186, against focal ischemic brain damage in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Inhibitory interaction between calcium channel blocker and clopidogrel. -Efficacy of cilostazol to overcome it-.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

The cardioprotective effect of a statin and cilostazol combination: relationship to Akt and endothelial nitric oxide synthase activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

CREB activation and ischaemic preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Single dose GLP-1-Tf ameliorates myocardial ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment: a potential role for phosphatase and tensin homolog deleted on chromosome ten?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Ischemic preconditioning involves dual cardio-protective axes with p38MAPK as upstream target

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Cilostazol, a phosphodiesterase inhibitor, improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty Rat, a model of spontaneous NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Cilostazol increases 3T3-L1 preadipocyte differentiation with improved glucose uptake associated with activation of peroxisome proliferator-activated receptor-gamma transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Cilostazol ameliorates metabolic abnormalities with suppression of proinflammatory markers in a db/db mouse model of type 2 diabetes via activation of peroxisome proliferator-activated receptor gamma transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Cardioprotection with postconditioning: loss of efficacy in murine models of type-2 and type-1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Regulation of phosphatase and tensin homolog on chromosome 10 in response to hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Use of cilostazol in percutaneous coronary interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Protein kinase A as another mediator of ischemic preconditioning independent of protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Cardioprotective effect afforded by transient exposure to phosphodiesterase III inhibitors: the role of protein kinase A and p38 mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Preconditioning the diabetic heart: the importance of Akt phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Structural basis for activation and inhibition of class I phosphoinositide 3-kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Phosphorylation of 5-lipoxygenase at ser523 by protein kinase A determines whether pioglitazone and atorvastatin induce proinflammatory leukotriene B4 or anti-inflammatory 15-epi-lipoxin a4 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

The potential effects of anti-diabetic medications on myocardial ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Aliskiren and Valsartan reduce myocardial AT1 receptor expression and limit myocardial infarct size in diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Type 2 diabetic obese db/db mice are refractory to myocardial ischaemic post-conditioning in vivo: potential role for Hsp20, F1-ATPase δ and Echs1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00609.2012

10.1152/AJPHEART.00609.2012

21 January 2018

Identifiers

DOI

1 reference

13 January 2018

PubMed ID

23103492

1 reference

13 January 2018